Cocaine addiction: an integration of treatments

Journal title PNEI REVIEW
Author/s Doris Radolovic
Publishing Year 2021 Issue 2021/1 Language Italian
Pages 13 P. 85-97 File size 1083 KB
DOI 10.3280/PNEI2021-001004
DOI is like a bar code for intellectual property: to have more infomation click here

Below, you can see the article first page

If you want to buy this article in PDF format, you can do it, following the instructions to buy download credits

Article preview

FrancoAngeli is member of Publishers International Linking Association, Inc (PILA), a not-for-profit association which run the CrossRef service enabling links to and from online scholarly content.

Scientific research has shown that substance addiction is a chronic relapsing disease with a multifactorial etiology, produced by the connection between biological, psychological and environmental factors. Cocaine is the second most commonly illicit drug used in Europe. Its consumption is now one of the most serious social problems and challenges to operators in various fields. Understanding how the different involved factors contribute to determine the vulnerability to the problematic use of cocaine is paramount for future prevention projects and treatments regarding this pathology. The integration of different therapies in this area does not only modify the global treatment effectiveness, but also opens new horizons of research regarding the pathology origin and the nature of the relationship that functionally links the biological, psychological and social aspects of addiction. Finally, some possible therapeutic approaches in the context of cocaine addiction are examined.

Keywords: Addiction, Cocaine, Pnei, Risk Factors, Integrative therapies, Multidisciplinary

  1. Belin D., & Deroche-Gamonet V. (2012). Responses to Novelty and Vulnerability to Cocaine Addiction: Contribution of a Multi-Symptomatic Animal Model. Cold Spring Harbor Perspectives in Medicine, 2(11), a011940–a011940. --
  2. Belin D., Berson N., Balado E., Piazza P.V., & Deroche-Gamonet V. (2011). High-Novelty-Preference Rats are Predisposed to Compulsive Cocaine Self-administration. Neuropsychopharmacology, 36(3), 569–579. --
  3. Carroll K.M., & Onken L.S. (2005). Behavioral Therapies for Drug Abuse. American Journal of Psychiatry, 162(8), 1452–1460. --
  4. Dackis C.A., Kampman K.M., Lynch K.G., Pettinati H.M., & O’Brien C.P. (2005). A Double-Blind, Placebo-Controlled Trial of Modafi nil for Cocaine Dependence. Neuropsychopharmacology, 30(1), 205–211. --
  5. Danese A., & Lewis S.J. (2017). Psychoneuroimmunology of Early-Life Stress: The Hidden Wounds of Childhood Trauma? Neuropsychopharmacology, 42(1), 99–114. --
  6. De Crescenzo F., Ciabattini M., D’Alò G.L., De Giorgi R., Del Giovane C., Cassar C., Janiri L., Clark N., Ostacher M.J., & Cipriani A. (2018). Comparative effi cacy and acceptability of psychosocial interventions for individuals with cocaine and amphetamine addiction: A systematic review and network meta-analysis. PLOS Medicine, 15(12), e1002715. --
  7. Diana M., Raij T., Melis M., Nummenmaa A., Leggio L., & Bonci A. (2017). Rehabilitating the addicted brain with transcranial magnetic stimulation. Nature Reviews Neuroscience, 18(11), 685–693. --
  8. DiNieri J.A., Nemeth C.L., Parsegian A., Carle T., Gurevich V.V., Gurevich E., Neve R.L., Nestler E.J., & Carlezon W.A. (2009). Altered Sensitivity to Rewarding and Aver sive Drugs in Mice with Inducible Disruption of cAMP Response Element-Binding Protein Function within the Nucleus Accumbens. Journal of Neuroscience, 29(6), 1855–1859. --
  9. Dube S.R., Felitti V.J., Dong M., Chapman D.P., Giles W.H., & Anda R.F. (2003). Childhood Abuse, Neglect, and Household Dysfunction and the Risk of Illicit Drug Use: The Adverse Childhood Experiences Study. PEDIATRICS, 111(3), 564–572. --
  10. Ersche K.D., Turton A.J., Chamberlain S.R., Müller U., Bullmore E.T., & Robbins T.W. (2012). Cognitive Dysfunction and Anxious-Impulsive Personality Traits Are Endophenotypes for Drug Dependence. American Journal of Psychiatry, 169(9), 926–936. --
  11. European Monitoring Centre for Drugs and Drug Addiction. (2020). European Drug Report 2020: trends and developments. LU: Publications Offi ce. -- retrieved 2021-04-01
  12. Gerra G., Leonardi C., Cortese E., Zaimovic A., Dell’Agnello G., Manfredini M., Somaini L., Petracca F., Caretti V., Raggi M.A., & Donnini C. (2009). Childhood neglect and parental care perception in cocaine addicts: Relation with psychiatric symptoms and biological correlates. Neuroscience & Biobehavioral Reviews, 33(4), 601–610. --
  13. Gerra G., Leonardi C., Cortese E., Zaimovic A., Dell’Agnello G., Manfredini M., Somaini L., Petracca F., Caretti V., Baroni C., & Donnini C. (2008). Adrenocorticotropic hormone and cortisol plasma levels directly correlate with childhood neglect and depression measures in addicted patients. Addiction Biology, 13(1), 95–104. --
  14. Grabowski J., Rhoades H., Schmitz J., Stotts A., Daruzska L.A., Creson D., & Moeller F.G. (2001). Dextroamphetamine for Cocaine-Dependence Treatment: A Double-Blind Randomized Clinical Trial: Journal of Clinical Psychopharmacology, 21(5), 522–526. --
  15. Jennings J.H., Sparta D.R., Stamatakis A.M., Ung R.L., Pleil K.E., Kash T.L., & Stuber G.D. (2013). Distinct extended amygdala circuits for divergent motivational states. Nature, 496(7444), 224–228. --
  16. Kampman K.M. (2019). The treatment of cocaine use disorder. Science Advances, 5(10), eaax1532. --
  17. Kendler K.S., Myers J., & Prescott C.A. (2007). Specifi city of Genetic and Environmental Risk Factors for Symptoms of Cannabis, Cocaine, Alcohol, Caffeine, and Nicotine Dependence. Archives of General Psychiatry, 64(11), 1313. --
  18. Koob G.F., & Moal M.L. (1997). Drug Abuse: Hedonic Homeostatic Dysregulation. Science, 278(5335), 52–58. --
  19. Koob G.F., & Volkow N.D. (2016). Neurobiology of addiction: a neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773. --
  20. Lo Iacono L., Catale C., Martini A., Valzania A., Viscomi M.T., Chiurchiù V., Guatteo E., Bussone S., Perrone F., Di Sabato P., Aricò E., D’Argenio A., Troisi A., Mercuri N.B., Maccarrone M., Puglisi-Allegra S., Casella P., & Carola V. (2018). From Traumatic Childhoodto Cocaine Abuse: The Critical Function of the Immune System. Biological Psychiatry, 84(12), 905–916. --
  21. Morrow J.D., & Flagel S.B. (2016). Neuroscience of resilience and vulnerability for addiction medicine. In: Progress in Brain Research (Vol. 223, pp. 3–18). Edinburgh: Elsevier.
  22. Northcutt A.L., Hutchinson M.R., Wang X., Baratta M.V., Hiranita T., Cochran T.A., Pomrenze M.B., Galer E.L., Kopajtic T.A., Li C.M., Amat J., Larson G., Cooper D.C., Huang Y., O’Neill C.E., Yin H., Zahniser N.R., Katz J.L., Rice K.C., Maier S.F., Bachtell R.K., & Watkins L.R. (2015). DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling. Molecular Psychiatry, 20(12), 1525–1537. --
  23. Olivares E.L., Kendler K.S., Neale M.C., & Gillespie N.A. (2016). The Genetic and Environmental Association Between Parental Monitoring and Risk of Cannabis, Stimulants, and Cocaine Initiation in a Sample of Male Twins: Does Parenting Matter? Twin Research and Human Genetics, 19(4), 297–305. --
  24. Pierce R.C., Fant B., Swinford-Jackson S.E., Heller E.A., Berrettini W.H., & Wimmer M.E. (2018). Environmental, genetic and epigenetic contributions to cocaine addiction. Neuropsychopharmacology, 43(7), 1471–1480. --
  25. Rachid F. (2018). Neurostimulation techniques in the treatment of cocaine dependence: A review of the literature. Addictive Behaviors, 76, 145–155. --
  26. Riezzo I., Fiore C., De Carlo D., Pascale N., Neri M., Turillazzi E., & Fineschi V. (2012). Side Effects of Cocaine Abuse: Multiorgan Toxicity and Pathological Consequences. Current Medicinal Chemistry, 19(33), 5624–5646. --
  27. Robison A.J., & Nestler E.J. (2011). Transcriptional and epigenetic mechanisms of addiction. Nature Reviews Neuroscience, 12(11), 623–637. --
  28. Shea A., Walsh C., MacMillan H., & Steiner M. (2005). Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology, 30(2), 162–178. --
  29. Strafella A.P., Paus T., Barrett J., & Dagher A. (2001). Repetitive Transcranial Magnetic Stimulation of the Human Prefrontal Cortex Induces Dopamine Release in the Caudate Nucleus. The Journal of Neuroscience, 21(15), RC157–RC157. --
  30. Van der Kolk B.A. (2008). Il disturbo traumatico dello sviluppo: verso una diagnosi razionale per bambini cronicamente traumatizzati. In: V. Caretti & G. Craparo (Eds.), Trauma e psicopatologia: un approcio evolutivo-relazionale. Roma: Astrolabio.
  31. Volkow N D, Fowler J.S., Wang G.-J., & Swanson J.M. (2004). Dopamine in drug abuse and addiction: results from imaging studies and treatment implications. Molecular Psychiatry, 9(6), 557–569. --
  32. Volkow Nora D., Koob G.F., & McLellan A.T. (2016). Neurobiologic Advances from the Brain Disease Model of Addiction. New England Journal of Medicine, 374(4), 363–371. --
  33. White S.L., Vassoler F.M., Schmidt H.D., Pierce R.C., & Wimmer M.E. (2016). Enhanced anxiety in the male offspring of sires that self-administered cocaine: Anxiety in cocaine-sired rats. Addiction Biology, 21(4), 802–810. --
  34. Wimmer M.E., Briand L.A., Fant B., Guercio L.A., Arreola A.C., Schmidt H.D., Sidoli S., Han Y., Garcia B.A., & Pierce R.C. (2017). Paternal cocaine taking elicits epigenetic remodeling and memory defi cits in male progeny. Molecular Psychiatry, 22(11), 1641–1650. --
  35. Yamada K., & Nabeshima T. (2004). Pro- and Anti-Addictive Neurotrophic Factors and Cytokines in Psychostimulant Addiction: Mini Review. Annals of the New York Academy of Sciences, 1025(1), 198–204. --
  36. Zuckermann M. (1988). Sensation seeking, risk taking and health. In: M. P. Janisse (Ed.), Individual Differences, Stress, and Health Psychology. New York, NY: Springer.

Doris Radolovic, La dipendenza da cocaina: verso un’integrazione delle cure in "PNEI REVIEW" 1/2021, pp 85-97, DOI: 10.3280/PNEI2021-001004